Intercept Pharmaceuticals
ICPT
$13.56
Share price
0.22%
Change (1 day)
-34.74%
Change (1 year)
Market capitalization of Intercept Pharmaceuticals (ICPT)
Market cap: $0.40 Billion
As of June 2022 Intercept Pharmaceuticals has a market cap of $0.40 Billion. This makes Intercept Pharmaceuticals the world's 5141th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Intercept Pharmaceuticals from 2012 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.35 B | -26.66% |
| 2021 | $0.48 B | -40.94% |
| 2020 | $0.81 B | -79.98% |
| 2019 | $4.07 B | 36.03% |
| 2018 | $2.99 B | 104.09% |
| 2017 | $1.46 B | -45.6% |
| 2016 | $2.69 B | -26.01% |
| 2015 | $3.64 B | 9.04% |
| 2014 | $3.34 B | 152.34% |
| 2013 | $1.32 B | 133.96% |
| 2012 | $0.56 B |
End of Day market cap according to different sources
On Jun 23rd, 2022 the market cap of Intercept Pharmaceuticals was reported to be:
$0.40 Billion
$0.40 Billion
$0.39 Billion
$0.40 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $309.39 B | 76,689.20% | 🇺🇸 USA |
 Gilead Sciences GILD | $79.78 B | 19,702.17% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $168.11 B | 41,624.13% | 🇺🇸 USA |
 MediciNova MNOV | $0.12 B | -68.35% | 🇺🇸 USA |